Skip to content
Open access

Blood Pressure, Kidney Function, and Kidney Mortality Among Mexican Adults.

Aug 2026 · American Journal of Kidney Diseases · 0 citations · 49 references
Medicine

TL;DR

Elevated BP as a major modifiable risk factor for kidney failure mortality, CKD, and albuminuria is highlighted in this large prospective study in Mexican adults.

Abstract

Rationale

&

Objective

Chronic kidney disease (CKD) is a major cause of death in Mexico and blood pressure (BP) may be an important contributor. This study investigated the associations of BP with CKD, albuminuria, and death from kidney failure. STUDY

Design

Prospective cohort study.

Setting

&

Participants

133,470 adults aged ≥35 to <85 years without CKD or other chronic disease (except diabetes), recruited from two districts of Mexico City between 1998 and 2004, and who survived ≥5 years after recruitment. A random subset of 9198 underwent additional evaluation 2015-2019. EXPOSURES Systolic BP (SBP), diastolic BP (DBP) and hypertension (participant report of taking blood pressure lowering medication or BP ≥140/90 mm Hg). OUTCOMES Kidney failure mortality during follow-up, and CKD (self-report and/or eGFR <60 mL/min/1.73m2) and albuminuria at the time of repeat clinical evaluation. ANALYTICAL APPROACH Multivariable Cox regression for the association of BP with kidney failure mortality and multivariable logistic regression for the association of baseline BP with CKD and albuminuria at the time of re-evaluation.

Results

Among all participants, SBP showed a continuous "log-linear" association with kidney failure mortality; each 20 mm Hg lower SBP being associated with 24% lower risk at ages 40-84 years (kidney failure death hazard ratio [HR] 0.76, 95% confidence interval 0.69-0.84). The association was stronger among those without diabetes (HR 0.54, 0.45-0.69) than with diabetes (HR 0.90, 0.80-1.01) but the absolute excess risk associated with higher BP was similar in these subgroups. Hypertension accounted for 9% of kidney failure deaths. Among those re-evaluated, 6% had developed CKD and 25% had albuminuria. 20 mm Hg lower baseline SBP was associated with 24% lower odds of both CKD (odds ratio [OR] 0.76, 0.68-0.85) and albuminuria (OR 0.76, 0.68-0.84) at the time of re-evaluation. Results were similar for DBP.

Limitations

Baseline urine samples were unavailable and kidney function trends over time could not be assessed.

Conclusions

This large prospective study in Mexican adults highlights elevated BP as a major modifiable risk factor for kidney failure mortality, CKD, and albuminuria.

Read PDF

Similar papers

Open access Aug 2026

Achieved systolic blood pressure and cardiovascular outcomes in advanced chronic kidney disease

In nephrology-referred patients with advanced CKD, achieved SBP around 120–<130 mmHg (near 125 mmHg) was associated with the lowest cardiovascular and mortality risk, while SBP ≥140 mmHg, especially ≥160 mmHg, was consistently associated with higher MACE risk.

Ehab Al-sodany, K. Szummer, Joakim Österman et al. · 0 citations
Open access Sep 2026

Blood pressure and cardiovascular risk in adults with non-proteinuric chronic kidney disease without diabetes.

A U-shaped association observed among individuals receiving antihypertensive treatment suggests that the relationship between BP and cardiovascular risk may be complex in this population, highlighting the potential importance of individualized clinical assessment.

Yuta Suzuki, Masachika Nishikawa, Hidehiro Kaneko et al. · 0 citations
Open access Sep 2026

Salt Intake and Kidney Outcomes in Older Adults With Chronic Kidney Disease: A Stage‐Specific Cohort Study

Excessive salt intake was associated with adverse kidney outcomes in CKD Stage 3 but not in Stages 4–5, and results suggest that salt restriction may be most beneficial in the early stages of CKD in this population.

Hiroaki Miyauchi, Tatsuhiko Azegami, Takashin Nakayama et al. · 0 citations
Open access Aug 2026

Risks of Major Adverse Kidney Events in Non-Hispanic Black Patients with Diabetes or Hypertension: A real-world cohort study.

Across two large cohorts at-risk for CKD, NHB patients experienced higher MAKE risk, shaped by neighborhood social and structural conditions rather than demographic and clinical characteristics alone.

Kiara N Mayhand, Anna M Zemke, Radica Z. Alicic et al. · 0 citations
Open access Aug 2026

Rationale and design of the EXCELSIOR-CKD trial: intensive blood pressure and lipid control in advanced chronic kidney disease.

As the first randomized trial to determine whether intensive SBP and LDL-C lowering improve kidney outcomes in advanced CKD, this study could help define optimal targets and inform future guideline recommendations.

Yaerim Kim, Jwa-Kyung Kim, Gang-Jee Ko et al. · 0 citations
Open access Sep 2026

Historical Gaps in Kidney and Cardiovascular Risk Assessment Among Patients with Diabetes and Hypertension: A Real-World Primary Care Study.

UACR testing was underutilized among patients with diabetes and hypertension, and consistent screening could have identified individuals who would benefit from guideline directed antiproteinuric therapies.

Jian Roushani, Sachin V. Pasricha, L. Dubrofsky et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.